PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins

Kerryn Berndsen1, Pawel Lis1, Wondwossen M Yeshaw2

  • 1MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.

Elife
|October 31, 2019
PubMed

Insights

Protein phosphatase PPM1H dephosphorylates Rab proteins, counteracting LRRK2 signaling implicated in Parkinson's disease. Enhancing PPM1H activity may offer new therapeutic strategies for Parkinson's disease.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mutations in Leucine-rich repeat kinase 2 (LRRK2) are a common cause of Parkinson's disease.
  • LRRK2 phosphorylates Rab GTPases, affecting their interactions with downstream effectors.
  • The dephosphorylation mechanisms counteracting LRRK2 signaling remain largely uncharacterized.

Purpose of the Study:

  • To identify protein phosphatases that regulate LRRK2 signaling.
  • To investigate the role of PPM1H in modulating LRRK2-mediated Rab phosphorylation.
  • To explore PPM1H as a potential therapeutic target for Parkinson's disease.

Main Methods:

  • siRNA screening of human protein phosphatases.
  • Cellular assays in A549 cells to assess Rab phosphorylation levels.
  • Biochemical studies using purified proteins and a substrate-trapping mutant of PPM1H.
  • Immunofluorescence to determine PPM1H localization and effect on primary cilia.

Main Results:

  • PPM1H was identified as a novel negative regulator of LRRK2 signaling.
  • PPM1H specifically dephosphorylates LRRK2-phosphorylated Rab proteins, including Rab8A.
  • PPM1H knockout enhanced Rab phosphorylation, while its overexpression suppressed it.
  • PPM1H knockdown impaired primary cilia formation, mirroring effects of pathogenic LRRK2.

Conclusions:

  • PPM1H acts as a key phosphatase counteracting LRRK2 activity by dephosphorylating Rab proteins.
  • PPM1H's function in regulating Rab phosphorylation and primary cilia formation highlights its importance in cellular homeostasis.
  • Modulating PPM1H activity presents a promising therapeutic avenue for Parkinson's disease.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.8K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.0K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.7K